Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Single-blind Phase I Study to Assess the Residual Allergenicity of Tree (Birch, Hazel and Alder) Pollen Allergoid Using Skin Prick Testing

NCT00107705 is registered in ClinicalTrials.gov with Allergy Therapeutics as lead sponsor.

NCT NCT00107705
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00107705 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Single-blind Phase I Study to Assess the Residual Allergenicity of Tree (Birch, Hazel and Alder) Pollen Allergoid Using Skin Prick Testing
Lead sponsor
Allergy Therapeutics
Phase
Phase 1
Overall status
Completed
Start date
April 30, 2005
Completion date
May 31, 2005
Enrollment
12
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

type i hypersensitivity